Abstract
High-dose intermittent cytarabine is an effective postremission treatment for patients with acute myeloid leukemia (AML). This regimen is a safe approach in patients < 60 years but produced severe neurotoxicity in the elderly. We have established a dose-reduced age-adapted consolidation using intermediate dose (IDAC; 2 x 1 g/m(2) i.v., days 1, 3, and 5) for AML patients >/= 60 years. Forty-seven de novo AML patients in complete remission (CR; median age, 70 years) were scheduled to receive four consolidation cycles of IDAC. In 25 of 47 patients (53%), all four cycles were administered: 9 (19%) received three cycles; 7 (15%) received two cycles; and 6 patients (12%) one cycle. Treatment was well tolerated without neurotoxicity. The median number of days with severe neutropenia (absolute neutrophil count < 500/microl) was 9. Neutropenic fever occurred in 22 of 47 patients (49%) during the first cycle, in 24 of 41 (60%) during the second, in 15 of 34 (44%) during the third, and in 18 of 25 (72%) during the fourth cycle. Only 1 patient died during consolidation (cardiac failure). The median overall survival, disease-free survival, and continuous CR were 10.6, 15.5, and 15.9 months, respectively. The probability of overall survival,...Continue Reading
References
Aug 1, 1976·British Journal of Haematology·J M BennettC Sultan
Aug 1, 1977·Cancer·B A Peterson, C D Bloomfield
Sep 1, 1992·Hematological Oncology·R BassanT Barbui
Jul 1, 1991·British Journal of Haematology·J M BennettC Sultan
Nov 1, 1991·British Journal of Haematology·J A Liu YinM J Lewis
Feb 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H TillyL Degos
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B LöwenbergS Suciu
Apr 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P A CassilethM J O'Connell
Jan 15, 1988·Cancer·C SebbanD Fiere
Oct 1, 1985·Annals of Internal Medicine·J M BennettC Sultan
Dec 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T BüchnerG Zeile
Jun 22, 1995·The New England Journal of Medicine·R M StoneC A Schiffer
Jan 1, 1994·British Journal of Haematology·M BaudardR Zittoun
Oct 6, 1994·The New England Journal of Medicine·R J MayerE Frei
Oct 1, 1993·British Journal of Haematology·P R JohnsonJ A Yin
Mar 1, 1996·Baillière's Clinical Haematology·B Löwenberg
Nov 5, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W HiddemannT Büchner
May 18, 2001·Best Practice & Research. Clinical Haematology·T BüchnerA Heinecke
Jul 27, 2001·Blood·R M StoneC A Schiffer
Aug 14, 2001·Critical Reviews in Oncology/hematology·A PintoF Ferrara
Sep 26, 2001·Cancer·E H Estey
Jun 13, 2002·Reviews in Clinical and Experimental Hematology·Thomas BüchnerUNKNOWN German AML Co-Operative Group
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards
Citations
Apr 1, 2006·Annals of Hematology·Je-Hwan LeeUNKNOWN Cooperative Study Group A for Hematology
Feb 19, 2015·European Journal of Haematology·Susana VivesUNKNOWN CETLAM Group
Jan 9, 2008·Genes, Chromosomes & Cancer·Katja HaasRotraud Wieser
May 3, 2005·Leukemia Research·Alexandra BöhmWolfgang R Sperr
Nov 28, 2006·Leukemia Research·Andrea ZatkovaPeter Valent
Sep 20, 2016·American Journal of Hematology·Wolfgang R SperrPeter Valent
Jun 3, 2017·Leukemia & Lymphoma·Jonathan A Webster, Keith W Pratz
Sep 28, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arnaud PigneuxUNKNOWN French Innovative Leukemia Organization
Jun 25, 2016·Oncotarget·Angélica CuapioErhard Hofer
Jul 13, 2017·American Journal of Hematology·Wolfgang R SperrPeter Valent
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maria-T KrauthPeter Valent
Jul 15, 2018·Wiener klinische Wochenschrift·Peter ValentChristoph Zielinski
Jan 5, 2021·Current Opinion in Hematology·Rory M Shallis, Nikolai A Podoltsev
Oct 6, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Wenhui LiTimothy Kubal